Evvy
San Francisco, United States · Founded 2021 · $19.0M raised
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2C
- Website
- evvy.com
- Total Funding
- $19.0M
- Last Round
- $14.0M Series ASep 2023
- Rounds
- 2
About
At-home vaginal microbiome testing and care platform offering metagenomic sequencing, clinician-reviewed results, personalized treatment, and consumer vaginal-health products.
Summary
Evvy is a Life Sciences company based in San Francisco, United States, founded in 2021. It has raised $19.0M in total across 2 rounds, most recently a $14.0M Series A round in Sep 2023. Investors include General Catalyst, Left Lane Capital and RH Capital.
Tech & App Stack
10 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...